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The relationship between tissue depletion and decreased exercise performance has been well established in patients
with COPD. In this study we investigated the influence of the pattern of tissue depletion on health related quality of
life (HRQL) and their mutual relationship with exercise capacity and dyspnoea.
Patients with low body weight and/or low fat-free mass (FFM; using bioelectrical impedance) were categorized in
three groups according to type of tissue depletion: loss of both FFM and fat mass (FM), and loss of FFM or FM
only. Handgrip strength (HGS) was used as a functional outcome measure of tissue depletion. Exercise
performance was assessed by 12min walking distance (12MWD) and dyspnoea by visual analogue scale (VAS).
HRQL was measured with the St George’s Respiratory Questionnaire (SGRQ) and the Medical Psychological
Questionnaire for Lung diseases (MPQL).
Patients with depletion of FFM irrespective of body weight showed greater impairment in 12MWD, HGS, the
‘activity’ and ‘impact’ scores of the SGRQ and the domain ‘invalidity’ of the MPQL, in comparison with depleted
patients with relative preservation of FFM. Exercise performance and dyspnoea were also significantly related to
these subscores of HRQL. In addition, dyspnoea related significantly to the domain ‘symptoms’ of the SGRQ.
Tissue depletion pattern remained significantly related to SGRQ-scores and the domain ‘invalidity’ of the MPQL
when dyspnoea and walking distance were added to the model as a covariates.
Tissue depletion is an important determinant of HRQL independent of exercise capacity and dyspnoea.
Key words: COPD; quality of life; body composition; pulmonary rehabilitation.
RESPIR. MED. (2000) 94, 859–867 # 2000 HARCOURT PUBLISHERS LTD
RESPIRATORY MEDICINE (2000) 94, 859–867
doi:10.1053/rmed.2000.0829, available online at http://www.idealibrary.com onIntroduction
Pulmonary rehabilitation is presently defined by the ERS
task force on rehabilitation and chronic care as a process
which systematically uses scientifically based diagnostic,
management and evaluation options to achieve the optimal
daily functioning and health related quality of life of
individual patients suering from impairment and disability
due to chronic respiratory disease, as measured by clinically
and/or physiologically relevant outcome measures (1).
The basic assumption of this definition is that in
pulmonary rehabilitation a number of treatments are used
in a logical and systemic fashion based on the recognition
that the impairment due to the chronic respiratory disease
leads to disability and reduction in quality of life. The
conceptual framework for understanding the dimensions of
the consequences of the disease, and the relationshipReceived 4 March 2000 and accepted 19 March 2000.
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0954-6111/00/090859+09 $35?00/0between them is set down in the International Classification
of Impairments, Disabilities and Handicaps (ICIDH)
published by the World Health Organization (WHO) (2).
Accordingly, impairment, is defined as ‘any loss or
abnormality of psychological, physiological or anatomical
structure or function’; disability, is defined as ‘any
restriction or lack (resulting from an impairment) of ability
to perform an activity in the manner or within the range
considered normal for a human being’; handicap, refers to
‘a disadvantage for a given individual, resulting from an
impairment or a disability, that limits or prevents the
fulfilment of a role that is normal (depending on age, sex,
social and cultural factors) for that individual’ (2).
In using the concept of this framework, we hypothesized
that in chronic obstructive pulmonary disease (COPD) the
disease specific impairment may be two-fold: impairment of
the respiratory organ system itself, including the ventilatory
pump, reflected by abnormal measures of lung and pump
function, and systemic impairment, which is manifested as
muscle wasting and changes in muscle metabolism, and is
reflected by alternations in muscle function. Dyspnoea and
decreased exercise performance can then be considered to# 2000 HARCOURT PUBLISHERS LTD
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systemic impairment, whereas handicap may represent the
disease specific health related quality of life (Fig. 1).
Several studies have demonstrated that pulmonary
rehabilitation clearly improves health related quality of life
in COPD patients. In a meta-analysis combining 14 trials
available in medical literature, Lacasse et al. (3) found
improvements in maximal exercise capacity and functional
exercise capacity, associated to improvements in health
related quality of life.
To be able to select the best possible candidates for
rehabilitation and to provide an individually based
programme, more insight is needed into the determinants
of quality of life. It is clearly established that resting lung
function measures are poorly related to quality of life (4–7).
This is perhaps not surprising since lung function is
moderately related to exercise capacity (8–11). Several
studies by our group and others have clearly shown in
recent years that tissue depletion is related to impaired
exercise capacity (12,13). Only limited information is
available regarding the relationship between weight loss
and changes in body composition with quality of life.
Weight loss commonly occurs in patients with severe
COPD (14). Furthermore several studies have shown that
depletion of fat-free mass may also occur in COPD despite
a normal stable body weight (12,15). In particular, loss of
fat-free mass has been shown to contribute to exercise
impairment in COPD (12–14).
Based on the clearly established relationship between
tissue depletion and decreased exercise tolerance in COPD
we hypothesized a relationship between tissue depletion and
health related quality of life. The aim of the present study
was therefore specifically to study the influence of the
pattern of tissue depletion on health related quality of life in
a group of COPD patients at risk. We furthermore tried toFIG. 1. Conceptual framework of International Classification of
to COPD.gain more insight in the mutual relationship between




The study group consisted of patients with COPD,
according to American Thoracic Society (ATS) guidelines
(16), admitted to the pulmonary rehabilitation centre. All
patients were in a stable clinical condition and none
suered from concommitant, confounding disorders. They
were studied in the evaluation phase prior to entering the
rehabilitation programme. Patients were consecutively
included into the study if they suered from a low body
weight [body mass index (BMI); weight(kg)/height(m)2]
and/or a low fat-free mas index [FFMI; fat-free mass (kg)/
height(m)2].
BODY COMPOSITION
Body height was measured standing barefoot and deter-
mined to the nearest 05 cm. Body weight was measured
with a beam scale to the nearest 01 kg without shoes and
wearing light clothing. Fat-free mass (FFM) was measured
by the bioelectrical impedance method. The resistance (BIA
101; RJL Systems, Detroit, MI, U.S.A.) was measured in
the supine position at the right side. FFM was calculated
from height2/resistance and body weight using a group
specific regression equation derived from a previous study
using deuterium dilution as a reference method (17).Impairments, Disabilities and Handicaps (ICIDH) applied
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Lung function measurements included forced expiratory
volume in 1 sec (FEV1) and the forced vital capacity (FVC)
(Masterlab; Jaeger Wurzburg, Germany). The best of three
eorts was selected. All volumes were expressed as a
percentage of the reference values (18).
MUSCLE FUNCTION
Muscle function was assessed by respiratory muscle
strength and handgrip strength. Inspiratory respiratory
muscle strength were determined by measuring respiratory
mouth pressures using the method of Black and Hyatt (19).
Maximal inspiratory mouth pressure (Pi-max) was mea-
sured at residual volume (RV). The highest value of three
manuoevres was selected. Pi-max measurement results in a
negative pressure, but in the present study it was expressed
and analysed in positive values. Values are expressed in
absolute terms.
Handgrip strength was used as a simple measure of
peripheral muscle strength. The force of the hand muscles
was measured with a Jamar Hand Dynamometer (Preston,
Jackson, Michigan, U.S.A.) on the non-dominant side with
the subject sitting, the forearm and hand in a direct line
with each other and resting on an armchair. At least three
isometric contractions at 1min intervals were performed.
The best of three readings was used for further analysis.
Values are expressed as kilogram force (kgf).
EXERCISE PERFORMANCE
Exercise performance was measured by a 12-min walking
test (12MWD), performed in a level enclosed corridor.
Patients were asked to walk as far as possible in 12min.
They could determine their own pace, even stop if
necessary, and they were instructed that at the end they
should feel as though they could not have walked any
further. No encouragement during the test was given. The
test was performed at a standardized item (between 13.00
and 14.00 h), and all patients performed one practice 12min
walking test.
DYSPNOEA
Patients were asked to rate their level of dyspnoea before
performing the 12-min walking test using a visual analogue
scale (VAS) of 100mm length (20). Dyspnoea was
expressed in mm, ranging from 0 to 100mm.
HEALTH RELATED QUALITY OF LIFE
Health related quality of life (HRQL) was measured with
the St. George’s Respiratory Questionnaire (SGRQ) (21)
and the Medical Psychological Questionnaire for Lung
Diseases (MPQL) (22).
The SGRQ, a 76 item respiratory-specific measure of
HRQL has a total score, plus subscores for symptoms,activity and impact. The ‘symptoms’ component contains
items on the level of symptomatology including frequency
of cough, sputum production, wheeze and breathlessness.
The ‘activity’ component is concerned with physical
activities that either cause or are limited by breathlessness.
The ‘impact’ component covers such factors as employ-
ment, being in control of health, panic, medication need
and side eects, and the disturbance of daily life. The three
components of HRQL are scored separately in the range
from 0 to 100 with a score of zero indicating no
impairment.
Since the SGRQ does not include a psychological
dimension, the components ‘well-being’ and ‘experienced
invalidity’ from the MPQL were added. ‘Well-being’
consists of 13 items [scores range from 13 (very unfavour-
able) to 39 (very favourable)] and measures mainly the state
of mind including anxiety. ‘Experienced invalidity’ consists
of 11 items [scores range from 11 (very favourable) to 33
(very unfavourable)] measuring a person’s perceived limita-
tions in physical activities due to his illness. Patients were
asked whether they agreed (score of 1), did not know (score
of 2), or disagreed (score of 3) with the described items.
STATISTICS
Patients were classified by BMI and FFMI. Patients were
considered underweight if their BMI 21kgm72 and were
considered as having a depleted FFM if FFMI15 kgm72
(women)/16 kgm72 (men). Based on the pattern of tissue
wasting, the following groups were defined: group 1:
BMI21 and FFMI 15 (,)/16 (<); group 2: BMI21
and FFMI415(,)/16(<); group 3: BMI421 and FFMI15
(,)/16 (<).
Comparisons of the three groups was done using analysis
of variance. Pearson correlation coecients were computed
between measures of body-composition, functional perfor-
mance and quality of life. Analysis of covariance was
performed between the pattern of tissue depletion and
health related quality of life, adjusting for measures of
functional impairment and disability. A P-value of less than
005 was considered significant.
All analyses were performed using the Statistical Package
for Social Sciences (SPSS Inc., Chicago, IL, U.S.A.). Unless
otherwise stated, data are presented as means+SD.
Results
Table 1 summarizes the characteristics of the study group
consisting of 32 men and 13 women with severe COPD
(total group: FEV1 33+12%pred.; FVC 81+18%pred.)
All patients participated in an inpatient pulmonary
rehabilitation programme. Categorization by pattern of
tissue depletion showed that 26 patients (58%) suered
from a loss of FM and FFM, seven patients (16%) had only
a low FM and 12 patients (26%) showed a loss of FFM in
spite of normal body weight.
Males and females were equally distributed between
groups, while patients in group 2 were younger.








BMI 4 21 and
FFMI 15(,)/16(<)
Men/women 18/8 6/1 8/4
Age (years)* 64 (8) 54 (12) 68 (6)
BMI (kgm72){ 188 (11) 199 (06) 221 (07)
FFMI (kgm72){ 145 (09) 164 (04) 147 (12)
FEV1 (l) 088 (026) 107 (069) 085 (025)
(% pred) 32 (8) 34 (19) 33 (13)
FVC (l) 285 (097) 344 (088) 249 (079)
(% pred) 81 (16) 89 (14) 76 (25)
12 MWD (m)* 640 (219) 836 (156) 585 (193)
HGS (kgf)* 296 (74) 381 (67) 294 (92)
Pi-max (cm H2O)* 63 (19) 81 (19) 62 (21)
VAS (mm) 29 (22) 40 (29) 40 (25)
BMI: body mass index; FFMI: fat free mass index; FEV1: forced expiratory volume in 1 sec; FVC: forced vital capacity; %
pred: percentage of predicted value; 12MWD: 12 min walking distance; HGS: hand grip strength; VAS: visual analogue scale;
Pi-max: maximal inspiratory mouth pressure. *P5005 and {P50001 for dierences between groups. For interpretation: see
text.
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FVC.
There was a significant relationship between category of
tissue depletion pattern and 12MWD (Fig. 2); in both
groups of patients with depletion of FFM irrespective of
body weight the distance walked was significantly lower
(group 1:640+219 m, group 3: 585+193 m), compared to
the patients with a low FM only (836+156 m).FIG. 2. Relationship between category of tissue depletion
and 12min walking distance (12MWD). *P5005. &:
Group 1; : group 2; &: group 3.Peripheral muscle strength, i.e. handgrip strength, was
also significantly related to the category of body composi-
tion showing a similar pattern as was found for 12MWD
(Fig. 3).
Respiratory muscle strength as determined by respiratory
mouth pressures was lower in both patient groups with loss
of FFM compared to patients with a low FM only, but this
dierence reached only statistically significance in group 1
compared to group 2 patients (P5005). VAS scores,
reflecting the sensation of dyspnoea at rest, were low in all
patient groups and were not dierent between the groups.
The relationship between category of tissue depletion
pattern and SGRQ subscores is given in Fig. 4. Patients
with a low FFM irrespective of low body weight had
significantly higher (i.e. greater impairment) ‘activity’
subscores compared to the patients with a low FM only
(group 1: 65+23 vs. group 2 :45+22, P5005 and group
group 3: 78+14, vs. group 2, P5005). No dierence in
‘activity’ score was found between groups 1 and 3.
The ‘impact’ subscore of the SGRQ was significantly
higher (i.e. greater impairment) in the subgroup of patients
with a low FFM only (group 3: 53+15 vs. group 1: 39+16,
P5005 and group 3 vs. group 2: 25+21, P5005).
No dierences between groups were found for the
subscore ‘symptoms’ of the SGRQ. Figure 4 depicts the
results of the MPQL. The component ‘well being’ was not
dierent between the patient groups (group 1: 24+8; group
2: 26,0+5,0; group 3: 19,0+8). Significantly higher values
for the component ‘invalidity’ indicative for more severe
impairment were found in both patient groups suering
from loss of FFM (group 1: 30+3 vs. group 2: 26+4
P5005; group 3: 32+2 vs. group 2, P5005).
The correlation coecients between measures of func-
tional impairment and disability with HRQL were as
FIG. 3. Relationship between category of tissue depletion
and ventilatory and peripheral muscle function. HGS:
handgrip strength; Pi-max: inspiratory mouth pressure.
*P5005. &: Group 1; : group 2; &: group 3.
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ventilatory pump function (Pi-max) and peripheral muscle
strength (HGS) were not significantly correlated with
subscores of the SGRQ or MPQL.
12MWD was significantly related to the SGRQ ‘activity’
score (r=7051; P5001) and ‘impact’ score (r=7047;
P5001) as well as to the component ‘invalidity’ of the
MPQL (r=70,44; P5005).
Dyspnoea related significantly to the SGRQ dimensions
‘impact’ and ‘symptoms’; correlation coecients for this
variable and SGRQ subscores were r=0,44 (P5005)
respectively. However, dyspnoea was not significantly
related to the domains of the MPQL.Results of analysis of covariance between the pattern of
tissue depletion and HRQL after adjustment for measures
of functional impairment were as follows (Table 2): when
handgrip strength and 12MWD were added to the model as
covariates, the pattern of tissue depletion was not
significantly related to the SGRQ. However, tissue deple-
tion pattern remained independently related to the compo-
nent ‘invalidity’ of the MPQL.
When Pi-max was added as a covariate instead of
handgrip strength the tissue depletion pattern remained
independently related to the domains ‘activity’ and ‘impact’
of the SGRQ and to the component ‘invalidity’ of the
MPQL.
A similar pattern was seen when analysis of covariance
was done based on the pattern of tissue depletion,
controlling for the covariates Pi-max and dyspnoea.
Dyspnoea related significantly to all subscores of the
SGRQ, except for an independent relationship with the
‘symptoms’ domain of the SGRQ. Again, here the tissue
depletion pattern remained independently related to the
domains ‘activity’ and ‘impact’ of the SGRQ and to the
component ‘invalidity’ of the MPQL.
Discussion
In this study we were particularly interested in the influence
of the pattern of tissue depletion on health related quality
of life, next to the influence of functional impairment in
these patients. We therefore focused on patients considered
to be depleted on the basis of decreased BMI and/or FFMI.
We found that patients exhibiting a depletion of fat free
mass, irrespective of body weight, had significantly higher
values of the ‘activity’ component of the SGRQ, indicative
for reduced quality of life. Particularly the patients in group
3 displaying a low FFM only, were characterized by higher
values for the subscore ‘impact’. The higher ‘impact’ score
of patients in group 3 probably reflects a worse functional
status in this group of patients compared to patients in
group 2, since ‘impact’ connotes the ability to perform (and
enjoy) the activities of daily life, including self-care skills
and mobility. This could be reflected in the higher ‘activity’
score, indicative for more severe impairment, and the more
reduced exercise performance in these patients compared to
patients in group 2.
No significant dierence was found between the groups
for the subscore ‘symptoms’ of the SGRQ comprising items
related to the level of symptomatology. Nevertheless, our
results are in keeping with the results of the study by Shoup
et al. (23) who observed that abnormally low fat-free mass
in patients with COPD was related to greater impairment in
all three subscores of the SGRQ.
In an earlier study by Ketelaars et al. (5) we found that
the HRQL components ‘activity’ and ‘impact’ were
negatively correlated with the results of the 12 min walking
test. Although these relationships were significant, the
correlations coecient values (r) were low, r=70,39 and
r=70,36 respectively. Furthermore, the 12 min walking
test could only partly explain the variance in the subscores
‘activity’ (R2=0,15) and ‘impact’ (R2=0,25) of the SGRQ.
FIG. 4. Relationship between category of tissue depletion and health related quality of life. SGRQ-score: results of St George
Respiratory Questionnaire, scores ranging from 0 to 100 with a lower score indicating less impairment; MPQL-score: results
of Medical Psychological Questionnaire, ‘well being’ ranging from 13 (very unfavourable) to 39 and ‘invalidity’ ranging from
11 to 33 (very unfavourable). *P5005. &: Group 1; : group 2; &: group 3.
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of the literature recently given by Curtis et al. (24) who also
observed weak but significant correlations (r-values ranging
from 0,07 – 0,41) between dierent variables of HRQL and
exercise tolerance, with an estimate of the proportion of the
variability in HRQL of R2=0,27.
In this study we found that body composition categories
were also related to the ‘activity’ and ‘impact’ SGRQ
scores, but walking distance was slightly better in predictingHRQL. The relevance of changes in body composition has
been shown in its adverse eect on physical performance
(12,13) as in 12min walking. In addition it was recently
demonstrated that in patients with COPD the 12min
walking test is performed at a relatively high metabolic and
ventilatory stress close to the stress developed at an
incremental symptom limited test on a cycle ergometer
(25). This can be attributed to the loss of FFM which has
been associated with atrophy of fast-twitch fibres in striated
TABLE 2. Results of analyses of covariance between tissue depletion pattern and HRQL adjusted for handgrip strength,
walking distance, Pi-max and dyspnoea
SGRQ MPQL
activity impact symptoms invalidity well-being
Pattern of depletion n.s. n.s. n.s. 5005 n.s.
Covariates handgrip strength n.s. n.s. n.s. n.s. n.s.
walking distance 5001 5005 n.s. n.s. n.s.
pattern of depletion 5005 5005 n.s. 5005 n.s.
Covariates Pi-max n.s. n.s. n.s. n.s. n.s.
walking distance 5001 5005 n.s. n.s. n.s.
pattern of depletion 5001 5001 n.s 50001 n.s.
Covariates Pi-max n.s. n.s. n.s. n.s. n.s.
dyspnoea 5001 5001 5005 5001 n.s.
n.s.: not significant.
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maximum muscle force output. Furthermore, an earlier
onset of anaerobic glycolysis (25,26) and metabolic acidosis
(13,27) and a decrease of local energy stores of exercising
muscles (13) have been postulated to explain early
fatiguability, and hence impaired exercise tolerance in these
patients. Finally, a less ecient breathing pattern, that is a
higher deadspace/VT ratio, as was demonstrated in COPD
patients with low body weight (13), may further contribute
to impaired exercise performance. In addition, Baarends
et al. (25) found that especially COPD patients with
depletion of FFM showed an impaired ability to increase
VT. Therefore, the 12min walking test can be considered as
an endurance test of relatively high intensity in these
patients, reflecting both loss of FFM as well as the
underlying metabolic changes. This suggests that the eects
of abnormalities in nutritional status on HRQL could be
mediated through changes in exercise ability. This finding is
in contrast with the results of Shoup et al. (23), who found
that lean body mass categories were not significantly related
to walking distance. However, we used the 12MWD which
has been shown to be more discriminative (12) than the 6
min walking distance used in their study. In addition to the
relationship between the pattern of tissue depletion and the
domains of the SGRQ we found that tissue depletion
pattern was significantly correlated with the subscore
‘experienced invalidity’ of the MPQL. Furthermore, this
subscore was significantly correlated with exercise perfor-
mance as measured by the 12min walking distance. This is
in accordance with the results of other investigators, who
also found a significantly relationship between ‘experienced
invalidity’ and exercise performance as measured by the
maximal load reached on a bicycle egrometer (r=70,28,
P50001) and the 12min walking test (r=70,28, P5001)
(22). Moreover, we found that tissue depletion pattern
remained significantly related to the component ‘experi-
enced invalidity’ of the MPQL when walking distance was
entered as a covariate to the model. This suggests that the
pattern of tissue depletion contributes also directly toHRQL as measured by the MPQL, independent of exercise
tolerance.
In this study we used handgrip strength as a measure of
peripheral muscle function. Muscle strength was signifi-
cantly lower in patients with loss of fat-free mass. Muscle
function is directly related to muscle mass and muscle
morphology. The reduction in peripheral muscle strength
can be explained by loss of fat-free mass since muscle
mass has been found to correlate strongly with muscle
strength in healthy older subjects (28). Furthermore, in
depleted patients with COPD changes in fibre composition
of the striated muscle has been found, that is a decrease in
type II fibres with relative sparing of the type I fibres,
resulting in an impaired maximum power output of the
muscles.
Weakness of peripheral muscles with lower values of
quadriceps muscle force compared to hand grip force has
been observed in patients with COPD (29). Although we
used HGS as a measure of peripheral muscle strength and
found it to be reduced in depleted patients, it seems
reasonable to expect that also quadriceps muscle force was
reduced in our patients (29). Reduced quadriceps force has
been shown not only to correlate with exercise limitation in
patients with COPD, but also with the use of healthcare
resources and limited self-care capabilities of these patients
(30), suggestive of worse HRQL. It can therefore be
speculated that the eect of impaired peripheral muscle
function, i.e. HGS on HRQL, could be mediated through
its eect on exercise performance.
In all patients low values for Pi-max were found
indicative of compromised ventilatory pump function.
However, no significant dierence between body composi-
tion categories was observed. The mechanisms leading to a
diminished function of the peripheral muscles—as was
observed in this study—are not likely to spare the
respiratory muscles. Indeed, several studies have reported
on the relationship between respiratory muscle dysfunction
and muscle wasting, both in COPD patients (31–34) as well
as in non-COPD patients (35). However, the decrease in
866 R. MOSTERT ET AL.ventilatory pump function that has been observed in
patients with COPD also stems from the mechanical
disadvantage to the (accessory) inspiratory muscles, includ-
ing the diaphragm, to hyperinflation (36, 37). Both factors
together are responsible for the observed decrease in
respiratory muscle function in these patients. For this
reason, a decrease in FFM would not necessarily lead to
detectable dierences in respiratory muscle strength, and
hence Pi-max.
In this study dyspnoea was the only factor related to all
subscores of the SGRQ in addition to its relationship with
‘experienced invalidity’ of the MPQL. This is in accordance
with the studies by Mahler et al. who demonstrated that
dyspnoea as measured by the baseline dyspnoea index
(BDI) was the single most important factor related to
general health status as measured by the Short Form-36
questionnaire and the severity of dyspnoea was a significant
predictor of the various components of HRQL (38). Also,
Shoup et al. (23) recently found that dyspnoea, measured
by BDI, was the strongest factor related to health related
quality of life as measured by the SGRQ. However, we
found that tissue depletion pattern was independently
related to the subscales ‘activity’ and ‘impact’ of the SGRQ
when dyspnoea was added as a covariate to the model. This
is in contrast with the results of the study by Shoup et al.
(23) who were unable to find such a relationship. This is
probably caused by the inclusion of overweight patients in
their study group, while we studied a more homogeneous
group of patients that were only included if they suered
from tissue depletion.
In summary, this study shows that tissue depletion is a
determining factor of health related quality of life as
measured by the SGRQ independent of exercise perfor-
mance and the sensation of breathlessness.
In correspondence with the ICIDH-concept, impairment
in COPD should be considered to be of a local and a
systemic nature, each with a separate and identifiable
influence on disability and handicap, i.e. quality of life. The
distinctions between impairment, disability and handicap
are both meaningful and important in pulmonary rehabi-
litation in order to focus on the individual requirements
and available treatment options for patients with chronic
respiratory disease. Whether reversion of depletion will
improve quality of life remains to be studied.
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